Preimplantation Genetic Testing (PGT) is a revolutionary advancement in assisted reproductive technology (ART), allowing embryologists to screen embryos for genetic abnormalities before implantation. This cutting-edge technique improves the chances of a successful pregnancy by selecting healthier embryos for transfer. 🏆
In this guide, we’ll explore the types of PGT, its applications in IVF, and why it’s a game-changer for embryologists and fertility specialists. 🚀
PGT is a laboratory procedure used in in vitro fertilization (IVF) to identify genetic abnormalities in embryos before they are implanted into the uterus. By screening embryos at the blastocyst stage (Day 5 or 6), embryologists can increase the chances of a successful pregnancy while reducing the risk of genetic disorders. 🏥
PGT has evolved significantly over the years:
1990s – First cases of genetic testing on embryos (PGD for monogenic disorders).
2000s – Introduction of comparative genomic hybridization (CGH) for chromosomal screening.
2010s – Advancements in Next-Generation Sequencing (NGS) improved accuracy and affordability.
Present – AI-powered embryo selection and non-invasive techniques are emerging. 🔍🤖
PGT is divided into three main categories, each serving a different purpose:
Purpose: Detects embryos with abnormal chromosome numbers (aneuploidy), such as Down syndrome (Trisomy 21).
Why It’s Important: Increases IVF success rates by ensuring only euploid embryos (46 chromosomes) are transferred.
Who Benefits?: Ideal for older women, those with recurrent miscarriages, or failed IVF cycles. 👶✅
Purpose: Screens embryos for single-gene (monogenic) disorders inherited from parents, such as:
Cystic fibrosis
Sickle cell anemia
Huntington’s disease
Why It’s Important: Helps carrier couples avoid passing on genetic diseases to their child.
Who Benefits?: Families with a known history of genetic disorders. 🏥🧬
Purpose: Detects chromosomal translocations, inversions, and deletions that can cause pregnancy loss or birth defects.
Why It’s Important: Prevents implantation failures and recurrent miscarriages caused by structural chromosomal abnormalities.
Who Benefits?: Couples with balanced translocations or a history of miscarriages. 💔➡️💖
✅ Higher IVF Success Rates – Selecting chromosomally normal embryos improves implantation chances.
✅ Reduces Miscarriages – Eliminates embryos with genetic abnormalities that may result in early pregnancy loss.
✅ Prevents Genetic Diseases – Helps families avoid passing on hereditary conditions.
✅ Increases Pregnancy Confidence – Patients can proceed with fewer concerns about genetic issues. 💕
🔹 Embryo Biopsy Risks – Though minimal, biopsy may slightly impact embryo viability.
🔹 False Positives/Negatives – Some genetic abnormalities may not be detected.
🔹 Cost Factor – PGT adds an extra expense to IVF cycles, making affordability a concern.
🔹 Ethical Concerns – Genetic testing raises debates over embryo selection and “designer babies.” ⚖️
🔬 Non-Invasive PGT (niPGT) – Researchers are developing techniques to analyze genetic material without biopsy.
🤖 AI-Powered Embryo Selection – Artificial intelligence may help predict embryo viability with greater accuracy.
📈 More Affordable Testing – As technology advances, costs will decrease, making PGT more accessible to all. 💰⬇️
Preimplantation Genetic Testing (PGT) is a game-changer in reproductive medicine, offering hope to countless families worldwide. 🌍 By allowing embryologists to select healthy embryos, PGT maximizes IVF success and reduces genetic risks.
As technology advances, PGT will become even more precise, affordable, and accessible, shaping the future of fertility treatments. 👶✨
Blastomere Biopsy Micropipettes
Holding Micropipettes
Injection Micropipettes
Polar Body Biopsy Micropipettes
Trophectoderm Biopsy Micropipettes Bevelled
Trophectoderm Biopsy Micropipettes Flat
5 ML Round Bottom Tubes
14 ML Round Bottom Tubes
35mm Dish
50 MM Dish
60mm Dish
Center Well Dish
Customer Support
Frequently Asked Questions
Chat on WhatsApp
Chat on FaceBook Messenger
Helpful Resources
Privacy Policy
© 2025 Monash Biotech. All Rights Reserved.
Designed & Developed by Goafreet Company